Lumos Diagnostics is closer than ever to a decision that could redefine its future: an FDA ruling that would open the entire US point-of-care market to Febridx.
Australia’s eSafety Commissioner has forced technology companies to hide disturbing content from children just weeks after the world’s first social media ban for under-16s takes effect.
